ICON Public Limited Company (ICLR)
NASDAQ: ICLR · Real-Time Price · USD
130.99
+0.15 (0.11%)
At close: May 29, 2025, 4:00 PM
131.07
+0.08 (0.06%)
After-hours: May 29, 2025, 4:00 PM EDT
ICLR Employees
ICON Public Limited Company had 41,900 employees as of December 31, 2024. The number of employees increased by 800 or 1.95% compared to the previous year.
Employees
41,900
Change (1Y)
800
Growth (1Y)
1.95%
Revenue / Employee
$195,528
Profits / Employee
$18,095
Market Cap
10.41B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 41,900 | 800 | 1.95% |
Dec 31, 2023 | 41,100 | 0 | - |
Dec 31, 2022 | 41,100 | 2,770 | 7.23% |
Dec 31, 2021 | 38,330 | 22,600 | 143.67% |
Dec 31, 2020 | 15,730 | 1,080 | 7.37% |
Dec 31, 2019 | 14,650 | 980 | 7.17% |
Dec 31, 2018 | 13,670 | 420 | 3.17% |
Dec 31, 2017 | 13,250 | 750 | 6.00% |
Dec 31, 2016 | 12,500 | 600 | 5.04% |
Dec 31, 2015 | 11,900 | 1,300 | 12.26% |
Dec 31, 2014 | 10,600 | 300 | 2.91% |
Dec 31, 2013 | 10,300 | 800 | 8.42% |
Dec 31, 2012 | 9,500 | 1,030 | 12.16% |
Dec 31, 2011 | 8,470 | 735 | 9.50% |
Dec 31, 2010 | 7,735 | 565 | 7.88% |
Dec 31, 2009 | 7,170 | 195 | 2.80% |
Dec 31, 2008 | 6,975 | 1,365 | 24.33% |
Dec 31, 2007 | 5,610 | 1,320 | 30.77% |
Dec 31, 2006 | 4,290 | 1,254 | 41.30% |
Dec 31, 2005 | 3,036 | 604 | 24.84% |
May 31, 2004 | 2,432 | 152 | 6.67% |
May 31, 2003 | 2,280 | 643 | 39.28% |
May 31, 2002 | 1,637 | 375 | 29.71% |
May 31, 2001 | 1,262 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
ICLR News
- 2 days ago - ICON plc to Present at the William Blair 45th Annual Growth Stock Conference - Business Wire
- 10 days ago - ICON releases its ICON Cares 2024 Report - Business Wire
- 22 days ago - Global ICON survey shows need for more efficient obesity clinical trial design to realise full potential of next-gen multi-indication therapies - Business Wire
- 27 days ago - ICON Public Limited Company (ICLR) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - ICON Reports First Quarter 2025 Results - Business Wire
- 7 weeks ago - GreensKeeper Q1 2025 Portfolio Update - Seeking Alpha
- 7 weeks ago - SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ICON - Accesswire
- 2 months ago - ICON plc Schedules First Quarter 2025 Earnings Conference Call - Business Wire